Related references
Note: Only part of the references are listed.lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer
Feng Qiu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
被撤回的出版物: Long noncoding RNA PEG10 facilitates bladder cancer cells proliferation, migration, and invasion via repressing microRNA-29b (Retracted article. See vol. 236, pg. 8256, 2021)
Tingting Liang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Long noncoding RNA FOXD3-AS1 promotes colon adenocarcinoma progression and functions as a competing endogenous RNA to regulate SIRT1 by sponging miR-135a-5p
Qiong Wu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
HBx-K130M/V131I Promotes Liver Cancer in Transgenic Mice via AKT/FOXO1 Signaling Pathway and Arachidonic Acid Metabolism
Amy P. Chiu et al.
MOLECULAR CANCER RESEARCH (2019)
microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer
Peng Li et al.
STEM CELL RESEARCH & THERAPY (2019)
MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion
Chao Huang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p
Yuchong Peng et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Downregulation of the long noncoding RNA MBNL1-AS1 protects sevoflurane- pretreated mice against ischemia-reperfusion injury by targeting KCNMA1
Xue-Feng Li et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Effects of microRNA-135a on the epithelial-mesenchymal transition, migration and invasion of bladder cancer cells by targeting GSK3β through the Wnt/β-catenin signaling pathway
Xia-Wa Mao et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145
Guosong Jiang et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis
Xianglong Tian et al.
JOURNAL OF CANCER (2017)
LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway
Hui-Jin Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Long Noncoding RNA and Cancer: A New Paradigm
Arunoday Bhan et al.
CANCER RESEARCH (2017)
Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells
Jingjing Pan et al.
CANCER LETTERS (2016)
MicroRNAs as noninvasive biomarkers in bladder cancer detection: a diagnostic meta-analysis based on qRT-PCR data
Shuhui Xiao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2016)
Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy
Chi Han Li et al.
CURRENT GENOMICS (2015)
Identification and Validation of Long Noncoding RNA Biomarkers in Human Non-Small-Cell Lung Carcinomas
Hui Yu et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer
Xiao Peng Mao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Leonardo Salmena et al.
CELL (2011)
Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer (vol 17, pg v118, 2006)
Hans von der Maase et al.
ANNALS OF ONCOLOGY (2011)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Re: Cystectomy for transitional cell carcinoma of the bladder: Results of a surgery only series in the neobladder era
Peter Albers
EUROPEAN UROLOGY (2008)
PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms
John Brognard et al.
MOLECULAR CELL (2007)
FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer
Xue-Yuan Dong et al.
CANCER RESEARCH (2006)
Long-term-survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer
H von der Maase et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
PHLPP: A phosphatase that directly dephosphorylates akt, promotes apoptosis, and suppresses tumor growth
TY Gao et al.
MOLECULAR CELL (2005)
Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
JP Stein et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
